PBM Enacted State Laws Database
The PBM Enacted Laws Database utilizes an interactive U.S. Map to identify and generate a list of relevent PBM enacted laws by any combination of issue areas and states, specific to your needs. By using the below interactive U.S. map, you can filter all laws by issue area to see all state laws for that issue. By selecting a specific state, you can see all enacted laws for that state. Additionally, the interactive map links the Enacted Law Database with the documents library to see all relevent documents for a filtered issue area. See the Tips for Using The Map icon below to learn more.
Can’t find what you are looking for? Contact Varbah Flumoku at vflumoku@pcmanet.org.
Issue Areas
- 340b
- Affiliate Pharmacies/Anti-Steering
- Audit
- Any Willing Pharmacy
- Biosimilars
- Copay Accumulator
- Copay Cap
- Clawback/Gag Order
- Disclosure/Transparency
- ERISA
- Fees
- Frozen Formulary
- Gold Carding
- Generic Substitution/Therapeutic Interchange
- Licensure/Registration
- MAC
- Mail-Order
- Network Adequacy
- PBM Duty of Care
- Pharmacy Accreditation
- Pharmacy Reimbursement
- POS Rebates
- PSAO
- Prompt Pay
- Specialty
- Spread Pricing
- Utilization Management
- White Bagging
*Most recent Enacted Law updates made on April 18, 2024.
Document Library
Navigate PCMA’s database of documents, including all advocacy materials, state specific comment letters, PCMA’s most up to date research and white papers, and any other relevant state materials. Use the filter tool navigate documents by issue area, state, or document type. As well, you can use the search box to navigate based on any specific key words. The document library is updated weekly with new material.
Can’t find what you are looking for? Contact Varbah Flumoku at vflumoku@pcmanet.org
Data Shows That Manufacturer Drug Price Increases Are Unrelated To Pbm Negotiated Rebates (Infographic)
Delivery Of Biosimilars to Patients Concentrated in Non-retail Settings (Infographic)
PBMs Use Competition to Negotiate Lower Net Costs for Hepatitis C Treatments (Infographic)
“Delinking” Means Drug Companies Win, While Taxpayers and Patients Lose (Infographic)
White Bagging Dispensing: Convenient and Less Costly (Report)
Potential Effects of Disclosing Price Rebates on the Medicare Drug Benefit (CBO)
FTC and US Department of Justice Antitrust Division Report–Improving Health Care A Dose of Competition
MN HF 2466 (2024)